Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedernewsroom.regeneron.com
Get the latest updates from Regeneron Pharmaceuticals Inc. News Releases directly as they happen.
Follow now 144 followers
Last updated about 20 hours ago
about 20 hours ago
TARRYTOWN, N.Y., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ...
2 days ago
36 abstracts to be presented across Regeneron -invented therapies, including first-time Phase...
10 days ago
New presentations include final 64-week results from the Phase 3 QUASAR trial...
13 days ago
Fourth quarter 2025 revenues increased 3% to $3.9 billion versus fourth quarter...
22 days ago
The Regeneron Science Talent Search Honors America’s Brightest Young Scientists Advancing Discovery...
about 1 month ago
TARRYTOWN, N.Y. , Jan. 02, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc...
about 2 months ago
Approval based on global Phase 3 program in children demonstrating Dupixent significantly...
about 2 months ago
TARRYTOWN, N.Y. , Dec. 22, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc...
2 months ago
All three dose groups (50 mg, 100 mg and 200 mg) showed...
2 months ago
TSRA-196 is a potential one-time treatment to precisely correct the genetic mutation...
3 months ago
Approval based on Phase 3 trials showing Dupixent significantly reduced itch and...
3 months ago
First and only FDA-approved treatment for RVO indicated for up to every...